Harmony Biosciences Holdings (HRMY) Accounts Payables (2019 - 2026)

Harmony Biosciences Holdings' Accounts Payables history runs 8 years deep, the most recent figure standing at $28.6 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 63.81% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $28.6 million (up 63.81% YoY), while the FY2025 annual figure was $17.7 million, up 28.73% from the prior year.
• Accounts Payables came in at $28.6 million for Q1 2026 at Harmony Biosciences Holdings, up from $17.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $28.6 million in Q1 2026 to a low of $3.8 million in Q4 2022.
• A 5-year average of $14.4 million and a median of $13.7 million in 2024 frame the typical range for Accounts Payables.
• On a YoY basis, Accounts Payables climbed as much as 368.3% in 2023 and fell as far as 34.93% in 2023.
• Harmony Biosciences Holdings' Accounts Payables stood at $3.8 million in 2022, then soared by 368.3% to $17.7 million in 2023, then fell by 22.48% to $13.7 million in 2024, then gained by 28.73% to $17.7 million in 2025, then jumped by 61.65% to $28.6 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $28.6 million, $17.7 million, and $26.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison